C4 Therapeutics, Inc.CCCCNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank43
Studio
Year-over-Year Change

Return on equity

Latest
-40.92%
↓ 79% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
-22.85%
Historical baseline
PeriodValueYoY Change
2025-40.92%+16.1%
2024-48.76%+9.4%
2023-53.83%-21.5%
2022-44.32%-105.8%
2021-21.53%+8.9%
2020-23.62%-177.6%
201930.46%+54.6%
201819.70%-